- Medtronic (NYSE:MDT) fiscal Q1 results: Revenues: $4,273M (+4.7%); U.S.: $2,333M (+5.8%); International: $1,940M (+3.4%); COGS: $1,105M (+8.1%); Operating Expenses: $2,085M (+9.3%); Net Income: $871M (-8.6%); EPS: $.87 (-6.5%); Quick Assets: $13.96B; CF Ops: $310M (-68.5%).
- Cardiac Rhythm & Heart Failure: $1,256M (+5.3%); Coronary & Structural Heart: $766M (+2.4%); Aortic & Peripheral: $232M (+5.9%); Spine: $743M (-2.9%); Neuromodulation: $479M (+11.9%); Surgical Technologies: $381M (+5.5%); Diabetes Group: $416M (+12.7%).
- Fiscal 2015 Guidance: revenue growth: 3 - 5%; non-GAAP EPS: $4.00 - 4.10.
Check out Seeking Alpha’s new Earnings Center
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at Zacks.com (Thu, 2:30PM)
at Zacks.com (Feb 26, 2015)
at Zacks.com (Feb 24, 2015)
UPDATE: Medtronic plc: FDA Approves the VenaSeal Closure System for Treatment of Clinically Symptomatic Venous Refluxat Benzinga.com (Feb 24, 2015)
at Zacks.com (Feb 23, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs